Ftse Mib
33.778,74
-1,51%
DAX
17.932,17
-1,10%
S&P 500
5.035,69
-1,57%
NASDAQ Composite
15.657,82
-2,04%
Bitcoin
60.175,28
-5,74%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Ampio Pharmaceuticals Inc (AMPE) Ampio Pharmaceuticals Inc (AMPE) Notizie

Ampio Pharmaceuticals Inc

AMPE
0,62
0,00 (0,00%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 02:00:00
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/4/202420:33PRNUSAmpio Pharmaceuticals Received Audit Opinion with Going..
25/3/202422:00PRNUSAmpio Announces Voluntary Delisting and SEC Deregistration
05/3/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
28/2/202421:49EDGAR2Form 8-K - Current report
28/2/202421:48EDGAR2Form S-8 POS - Securities to be offered to employees in..
28/2/202421:47EDGAR2Form S-8 POS - Securities to be offered to employees in..
28/2/202421:46EDGAR2Form POS AM - Post-Effective amendments for registration..
28/2/202421:45EDGAR2Form RW - Registration Withdrawal Request
15/2/202415:31EDGAR2Form 8-K - Current report
14/2/202423:45PRNUSAmpio Provides Update on Results from Pre-IND Enabling..
25/1/202422:31EDGAR2Form 8-K - Current report
25/1/202422:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24/1/202423:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/1/202422:20EDGAR2Form 8-K - Current report
11/1/202422:15PRNUSAmpio Provides Litigation Update - Reports Settlement in..
21/12/202322:25EDGAR2Form S-1 - General form for registration of securities under..
14/11/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202314:30EDGAR2Form 8-K - Current report
31/10/202314:00PRNUSAmpio Pharmaceuticals to Present at the Emerging Growth..
27/10/202320:10EDGAR2Form 8-K - Current report
06/10/202320:56EDGAR2Form 8-K - Current report
05/10/202322:30PRNUSAmpio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO..
04/10/202322:15EDGAR2Form 8-K - Current report
26/9/202315:15PRNUSAmpio Pharmaceuticals to Present at the Emerging Growth..
22/9/202322:30EDGAR2Form 8-K - Current report
18/9/202322:30EDGAR2Form S-3 - Registration statement under Securities Act of..
31/8/202322:19EDGAR2Form 8-K - Current report
31/8/202312:30PRNUSAmpio Pharmaceuticals Announces Reverse Stock Split
15/8/202322:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202322:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/7/202317:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
05/7/202322:37EDGAR2Form 8-K - Current report
26/5/202322:40PRNUSAmpio Pharmaceuticals Announces Series D Preferred Stock..
Apertura: Min: Max:
Chiusura: 0,62

La tua Cronologia

AMEX
AMPE
Ampio Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network